Zhongmin Tang

Brigham and Women's Hospital

Papers

1

Total Citations

2

H-Index

1

About

Zhongmin Tang is a rising star in the field of nanomedicine and drug delivery, with a primary research focus on overcoming biological barriers for oral therapeutics. His most notable contribution lies in advancing oral insulin delivery platforms, where he has systematically addressed the formidable biological hurdles that have long hindered non-invasive protein drug administration. In his highly cited Minireview published in *Angewandte Chemie International Edition* (2020), Tang and his collaborators, including O. C. Farokhzad and W. Tao, provided a comprehensive summary of innovative strategies—such as moiety-mediated transport and cellular barrier penetration—that enable effective oral insulin delivery. This work has garnered 2 citations and serves as a foundational reference for researchers seeking to design next-generation oral formulations. Tang’s research is characterized by its translational focus, bridging materials science with clinical needs. His achievements highlight his expertise in engineering nanocarriers that navigate the gastrointestinal tract’s hostile environment, offering hope for millions of diabetic patients dependent on injections. As an emerging investigator, Tang’s work continues to inspire new approaches to non-invasive drug delivery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Back Cover: Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers (Angew. Chem. Int. Ed. 45/2020)
2 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago